Diagnostic evaluation of papillary lesions of the breast on core biopsy

Modern Pathology

Volumn 23, Issue 7, 2010, Pages 1021-1028

  Pathmanathan, Nirmala ^a,b,c,d   Albertini, Ann Flore ^a   Provan, Pamela J ^c,d   Milliken, Jane S ^a   Salisbury, Elizabeth L ^a,b   Bilous, A Michael ^a,d   Byth, Karen ^c   Balleine, Rosemary L ^c,d  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b BreastScreen Western Sydney   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

breast; papillary; papilloma; pathology core biopsy

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; KI 67 ANTIGEN; PROTEIN P63; TUMOR MARKER;

ARTICLE; BIOPSY TECHNIQUE; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; BREAST PAPILLOMA; CELL PROLIFERATION; CONTROLLED STUDY; CORE BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR CLASSIFICATION; BIOPSY; BREAST TUMOR; FEMALE; METABOLISM; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PATHOLOGY;

BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMA, INTRADUCTAL; TUMOR MARKERS, BIOLOGICAL;

EID: 77954244507     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.81     Document Type: Article

References (17)

1. Mulligan AM, O'Malley FP. Papillary lesions of the breast: a review. Adv Anat Pathol 2007;14:108-119.
2. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histo-pathology 2008;52:20-29.
3. Liberman L, Bracero N, Vuolo MA, et al. Percutaneous large-core biopsy of papillary breast lesions. AJR Am J Roentgenol 1999;172:331-337.
4. Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006;238:801-808.
5. Sydnor MK, Wilson JD, Hijaz TA, et al. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007;242:58-62.
6. Tseng HS, Chen YL, Chen ST, et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol 2009;35:21-24.
7. Rizzo M, Lund MJ, Oprea G, et al. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol 2008;15:1040-1047.
8. Tse GM, Tan PH, Moriya T. The role of immunohis-tochemistry in the differential diagnosis of papillary lesions of the breast. J Clin Pathol 2009;62: 407-413.
9. Skandarajah AR, Field L, Yuen Larn Mou A, et al. Benign papilloma on core biopsy requires surgical excision. Ann Surg Oncol 2008;15:2272-2277.
10. Bode MK, Rissanen T, Apaja-Sarkkinen M. Ultrasono-graphy-guided core needle biopsy in differential diagnosis of papillary breast tumors. Acta Radiol 2009;50:722-729.
11. Bernik SF, Troob S, Ying BL, et al. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up. Am J Surg 2009;197:473-478.
12. Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006;30: 665-672.
13. de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, et al. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast. Breast J 2008;14:68-75.
14. Douglas-Jones A, Shah V, Morgan J, et al. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63. Histopathology 2005;47:202-208.
15. Ichihara S, Fujimoto T, Hashimoto K, et al. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast. Pathol Int 2007;57:126-132.
16. Shah VI, Flowers CI, Douglas-Jones AG, et al. Im-munohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology 2006;48:683-691.
17. Grin A, O'Malley FP, Mulligan AM. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. Am J Surg Pathol 2009;33: 1615-1623.